CPHINYSEPharmaceutical PreparationsFiscal year ends December 31
CHINA PHARMA HOLDINGS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.69−0.02 (-3.49%)
Close on Oct 19, 2026
- Market cap
- $27.76M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$1.1389 (−62.44%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
CHINA PHARMA HOLDINGS, INC. saw revenue fall 11.0% to $3.91M over the twelve months to Jun 30, 2026. Free cash flow was $88.94K.
Revenue
$3.91M
-11.0% vs. a year earlier
Operating income
-$4.38M
TTM Q2 2026
Free cash flow
$88.94K
FY2025
EPS, diluted
-$0.43
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $27.76M
- P/E ratio
- –
- Price to sales
- 7.09
- Price to book
- 0.77
- Dividend yield
- –
- Free cash flow yield
- 0.32%
Fundamentals
- Revenue
- $3.91M
- Net income
- -$4.47M
- EPS, diluted
- -$0.43
- Free cash flow
- $88.94K
- Book value per share
- $0.89
- Diluted shares
- 41M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$3.91M-11.0% YoY
Gross profit
$460.17K
Operating income
-$4.38M
Net income
-$4.47M
EPS, diluted
-$0.43
Free cash flow
–
Reported periodTrailing twelve months